Search
for
Sort by
Research 31–60 of 1000+
- Adverse Cutaneous Reactions to Antidepressants
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Immunomodulators in the treatment of cutaneous lymphoma
- Cutaneous Reactions to Drugs
- Urticariform plaques: delayed hypersensitivity reaction type IV to enoxaparin
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- Adverse cutaneous effects of psychotropic medications
- Cutaneous signals of immune system disease
- Severe cutaneous adverse reactions to drugs
- Lupus erythematosus: systemic and cutaneous manifestations
- Cutaneous reactions to recombinant cytokine therapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous lupus erythematosus
- Cutaneous and Mucosal Manifestations Associated with Celiac Disease
- Cutaneous Side Effects of Oral Contraceptives
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- A CLINICAL STUDY OF CUTANEOUS MANIFESTATIONS IN PATIENTS WITH THYROID DISORDERS
- HHV-6A and HHV-6B in Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms
- Immune response involving the bulge region in addition to telogen conversion contributes to hair loss in a case of atypical drug-induced hypersensitivity syndrome
- Cutaneous adverse reactions associated with enfortumab vedotin: a pharmacovigilance study based on the FDA adverse event reporting system
- Cutaneous manifestations of COVID-19 and vaccines for its prevention: a review of the existing literature
- Performance of Chlorhexidine and Ophytrium-Containing Shampoo and Mousse in Dogs with Cutaneous Yeast Imbalance
- Cutaneous lupus erythematosus. Diagnostic and therapeutic recommendations of the Polish Dermatological Society
- Localized cutaneous necrosis associated with the antiphospholipid syndrome
- Hypersensitivity reactions to anticoagulant drugs: diagnosis and management options
- Hypersensitivity Reactions to Anticoagulant Drugs